Table 2.

Correlations Between the In Situ TSIA and MTX Accumulation or MTX Polyglutamylation

Total MTX Accumulation (pmol/109 cells) Percentage MTX-Glu4-6
rPn rPn
TSI50,cont. MTX (μmol/L) −.51  <.001  47  −.03  .87  42 
TSI50,short MTX (μmol/L)  −.58  <.001 43  −.29  .07  39  
TSI50,shortMTX/TSI50,cont. MTX  −.28  .14  30  −.48 .01  27 
Total MTX Accumulation (pmol/109 cells) Percentage MTX-Glu4-6
rPn rPn
TSI50,cont. MTX (μmol/L) −.51  <.001  47  −.03  .87  42 
TSI50,short MTX (μmol/L)  −.58  <.001 43  −.29  .07  39  
TSI50,shortMTX/TSI50,cont. MTX  −.28  .14  30  −.48 .01  27 

Spearman’s correlation coefficients (r) of TSI50 values for MTX of patient-derived leukemic blast cells obtained with the TSIA and MTX accumulation over 24 hours in 1 μmol/L [3H]-MTX or polyglutamylation efficiency defined as percentage of total accumulated MTX present as MTX-Glu4-6. For T-ALL, median accumulation of MTX was 630 pmol/109 cells (range, 314 to 1316 pmol/109cells), median percentage MTX-Glu4-6 was 41% (range, 0% to 85%). For c/preB-ALL, median accumulation of MTX was 1364 pmol/109 cells (range, 521 to 3068 pmol/109cells), median percentage MTX-Glu4-6 was 72% (range, 34% to 82%). TSI50 values were determined either after 21 hours continuous MTX exposure (TSI50,cont.) or after 3 hours of MTX incubation followed by an 18-hour drug-free period (TSI50,short).

or Create an Account

Close Modal
Close Modal